Hill Rom Holdings Inc (HRC) Return on Investment ROI from the fourth quarter of 2021 to fourth quarter of 2020 and for the year 2021, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Hill rom Holdings Inc   (NYSE: HRC)


Hill Rom Holdings Inc's ROI from its fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Hill Rom Holdings Inc's ROI in the fourth quarter of 2021?
Hill rom Holdings Inc achieved a return on average invested assets (ROI) of 9.17 % in its fourth quarter of 2021, this is above HRC's average return on investment of 4.64%.
Hill Rom Holdings Inc s investments during the 12 months ending in the fourth quarter of 2021 are valued at $2 billion

ROI has improved compared to 6.52% in the third quarter of 2021, due to net income growth.

Within the Healthcare sector 118 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2021 from 965 to 1211.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2021)
IV. Quarter		 (Jun 30 2021)
III. Quarter		 (Mar 31 2021)
II. Quarter		 (Dec 31 2020)
I. Quarter		 (Sep 30 2020)
IV. Quarter
Y / Y Investment Change TTM -26.47 % -0.8 % -0.47 % -1.07 % -0.09 %
Y / Y Net Income Change TTM 11.43 % 13.91 % 146.25 % 257.46 % 699.28 %
Investment (TTM) in Millions 0 3,516 3,694 3,635 3,719
Return On Investment (TTM) 9.17 % 6.52 % 7.67 % 6.61 % 6.05 %
HRC's Overall Ranking # 1211 # 965 # 220 # 243 # 717
Seq. Investment Change TTM -25.53 % -1 % 0.38 % -0.65 % 0.46 %
Seq. Net Income Change TTM 4.63 % -15.84 % 16.61 % 8.52 % 6.95 %
Net Income (TTM) in Millions 249 238 282 242 223

HRC Company Profile >> Back to HRC Roi Comparisons >> See Annual HRC Return On Investment



Return On Investment HRC's Ranking
Within: No.
Industry # 34
Sector # 119
Overall # 1211

Return On Investment Statistics
High Average Low
8.89 %
4.64 %
1.09 %
(Sep 30 2021)   (Mar 31 2016)







Financial Statements
Hill Rom Holdings Inc's IV. Quarter Investments $ 0 Millions HRC's Balance sheet
Hill Rom Holdings Inc's IV. Quarter Income $ 53 Millions Quarterly HRC's Income Statement
HRC's Income by Division See HRC's Income by Division


HRC Annual Return On Investment (Sep 30 2021)
2021		 (Sep 30 2020)
2020		 (Sep 30 2019)
2019		 (Sep 30 2018)
2018		 (Sep 30 2017)
2017
Total Investments in Millions 0 3,719 3,651 3,698 3,877
Y / Y Investment Growth -100 % 1.87 % -1.27 % -4.64 % 7.44 %
Net Income in Millions 249 223 152 252 132
Y / Y Net Income Growth 11.43 % 46.52 % -39.7 % 90.78 % 7.74 %
Annual Return On Investment 6213898.13 % 6 % 4.17 % 6.83 % 3.41 %


Annual Roi Comment
In the fiscal year 2021 ROI improved to 6213898.13 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HRC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HRC's Competitors
Subscribers only: Roi for Hill Rom Holdings Inc's Suppliers
Subscribers only: Return On Investment for HRC's Customers

Other Ratios
HRC's Roa HRC's Inventory Turnover Ratio HRC's Growth Rates HRC's Dividend Statistics
HRC's Profitability Ratios HRC's Asset Turnover Ratio HRC's Dividend Growth
HRC's Roe HRC's Valuation Ratios HRC's Financial Strength Ratios HRC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2021, within Healthcare Sector ROI
Tivity Health Inc   25.10 %
Elite Pharmaceuticals Inc   24.48 %
Encision Inc   23.71 %
Dyadic International Inc   23.56 %
Vaso Corporation  23.38 %
Collegium Pharmaceutical Inc   23.26 %
Edwards Lifesciences Corporation  22.41 %
Sana Biotechnology Inc   22.32 %
Catalyst Pharmaceuticals Inc   22.25 %
Organogenesis Holdings Inc   22.02 %
Vertex Pharmaceuticals Inc  21.16 %
Corcept Therapeutics Inc  20.28 %
Align Technology inc   20.16 %
Waters Corporation  18.90 %
Quest Diagnostics Inc  18.24 %
Amedisys Inc  18.07 %
Meridian Bioscience Inc   17.93 %
Lftd Partners Inc   17.65 %
Procyon Corporation  17.44 %
Eli Lilly And Company  17.40 %
Crispr Therapeutics Ag  17.16 %
Pro dex Inc   17.05 %
Biodelivery Sciences International Inc   16.86 %
Incyte Corporation  16.85 %
Prothena Corporation Public Limited Company  16.83 %
Atrion Corporation  16.54 %
Zoetis Inc   16.48 %
Medpace Holdings Inc   16.30 %
La Jolla Pharmaceutical Company  16.23 %
Masimo Corp  15.70 %

Date modified: 2026-09-08T15:10:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.